MetaADEDB 2.0 @ LMMD
Retinal vascular thrombosis
(UMLS:C0919714)
UMLS ID:
C0919714
MeSH ID:
N/A
Synonym(s)
1.
Retinal vascular thrombosis
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1Raloxifene HydrochlorideFAERS: 18US FAERS
2NorgestrelFAERS: 14OFFSIDES
US FAERS
3RivaroxabanFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
4rofecoxibFAERS: 8OFFSIDES
US FAERS
5CelecoxibFAERS: 5US FAERS
6LenalidomideFAERS: 4US FAERS
7LetrozoleFAERS: 4US FAERS
8ValsartanFAERS: 4US FAERS
9apixabanFAERS: 4US FAERS
10DutasterideFAERS: 3US FAERS
11Insulin GlargineFAERS: 3US FAERS
12Medroxyprogesterone AcetateFAERS: 3US FAERS
13OctreotideFAERS: 3US FAERS
14PantoprazoleFAERS: 3US FAERS
15Raloxifene HydrochlorideFAERS: 3OFFSIDES
US FAERS
16SorafenibFAERS: 3US FAERS
17TeriparatideFAERS: 3US FAERS
18WarfarinFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
19exemestaneFAERS: 3US FAERS
20DeferasiroxFAERS: 2US FAERS
21EstradiolFAERS: 2SIDER
US FAERS
22FentanylFAERS: 2US FAERS
23Fingolimod HydrochlorideFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
24LatanoprostFAERS: 2US FAERS
25MemantineFAERS: 2US FAERS
26NuvaRingFAERS: 2US FAERS
27ProgesteroneFAERS: 2US FAERS
28RisperidoneFAERS: 2US FAERS
29RosiglitazoneFAERS: 2US FAERS
30etonogestrelFAERS: 2US FAERS
31nintedanibFAERS: 2US FAERS
324-AminopyridineFAERS: 1US FAERS
334-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 1US FAERS
34AzacitidineFAERS: 1US FAERS
35CeftriaxoneFAERS: 1US FAERS
36ClopidogrelFAERS: 1US FAERS
37DabigatranFAERS: 1US FAERS
38EsomeprazoleFAERS: 1US FAERS
39Estrogens, Conjugated (USP)FAERS: 1US FAERS
40FinasterideFAERS: 1US FAERS
41Fluticasone-Salmeterol Drug CombinationFAERS: 1US FAERS
42Fosamax plus DFAERS: 1US FAERS
43HhAntag691FAERS: 1US FAERS
44Ibandronic AcidFAERS: 1US FAERS
45Imatinib MesylateFAERS: 1US FAERS
46LeuprolideFAERS: 1US FAERS
47LevofloxacinFAERS: 1US FAERS
48MeloxicamFAERS: 1US FAERS
49Ortho EvraFAERS: 1US FAERS
50PropranololFAERS: 1US FAERS
51QVA149FAERS: 1US FAERS
52QlairaFAERS: 1US FAERS
53Quetiapine FumarateFAERS: 1US FAERS
54Risedronic AcidFAERS: 1US FAERS
55Sildenafil CitrateFAERS: 1US FAERS
56SunitinibFAERS: 1US FAERS
57TadalafilFAERS: 1US FAERS
58ThalidomideFAERS: 1US FAERS
59beyazFAERS: 1US FAERS
60eltrombopagFAERS: 1US FAERS
61entecavirFAERS: 1US FAERS
62norgestimate, ethinyl estradiol drug combinationFAERS: 1US FAERS
63ponatinibFAERS: 1US FAERS
64trametinibFAERS: 1US FAERS
65valdecoxibFAERS: 1US FAERS
66venetoclaxFAERS: 1US FAERS
67AlprazolamOFFSIDES
68ClopidogrelOFFSIDES
69EstroneSIDER
70EzetimibeOFFSIDES
71GadoliniumOFFSIDES
72Lanthanum carbonate hydrateOFFSIDES
73LeflunomideOFFSIDES
74MedroxyprogesteroneSIDER
75MethyltestosteroneOFFSIDES
76MidodrineOFFSIDES
77MirtazapineOFFSIDES
78NabumetoneOFFSIDES
79NorethindroneSIDER
80OctreotideCanada Vigilance: 1Canada Vigilance
81Penicillin VOFFSIDES
82Prednisone acetateOFFSIDES
83Sitagliptin PhosphateOFFSIDES
84acetaminophen, dextropropoxyphene, drug combinationOFFSIDES
85calcium acetateOFFSIDES
86desloratadineOFFSIDES
87gadoversetamideOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.